CD79A and chronic myelogenous leukemia, BCR-ABL1 positive: Analyses of the KEGG pathway identified 25 pathways, in addition to cancer-related pathways, which included the chemokine signaling pathway, cell adhesion molecules, the cell cycle and hematopoietic cell lineage, the PPAR signaling pathway, chronic myeloid leukemia, and the intestinal immune network for IgA production.